The Bio-Based Economy: What’s Holding It Back?
As pollution and climate change become growing problems, breaking society’s addiction to fossil fuels is…
06/01/2021 - 9 minutes
Jonathan Smith
Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.
Wave of Acquisitions Hits ADC Cancer Treatment Space
The end of 2020 saw several big pharma acquisitions of companies developing antibody-drug conjugate drugs…
05/01/2021 - 7 minutes
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Humble Beginnings: The Origin Story of Modern Biotechnology
The history of modern biotechnology began around four decades ago with the invention of genetic…
23/12/2020 - 4 minutes
EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its…
22/12/2020 - 5 minutes
European Biotech Venture Capital Fundraising Surges as 2020 Closes
The last few months have seen a flurry of fundraises from European life sciences investors,…
11/12/2020 - 6 minutes
Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures
In spite of recent failures of clinical trials from others in the field, Swiss company…
07/12/2020 - 3 minutes
Can Anti-Aging Research Keep Us Healthy in the Long Run?
Searching for the fountain of eternal youth has been the dream of humanity for millennia.…
30/11/2020 - 10 minutes
ATAI’s €105M Series C Highlights Growing Interest in Psychedelics
While the UK remains the main European hub for psychedelics research, a recent €105M Series…
27/11/2020 - 5 minutes
SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’
The newly founded SynOx has become the latest startup to attack solid tumors via their…
23/11/2020 - 4 minutes
mRNA Stocks Soar with Final Results of BioNTech’s Covid-19 Vaccine
The field of messenger RNA therapeutics is flying high as BioNTech and Pfizer conclude a…
19/11/2020 - 6 minutes
Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal
Last week’s €1.75B deal between the German biotech Affimed and Swiss giant Roivant backs up…
16/11/2020 - 3 minutes
